OpenVSafe by OpenVAERS
Search V-safe

AVX-15385-04251

6 vaccinations 9 coded responses 14 check-ins 8 free-text entries 4 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
350 / AL
Registered
2021-03-19
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-29
    Dose 1 — Moderna
  2. 2021-01-26
    Dose 2 — Moderna
  3. 2021-03-19
    Registered in v-safe
  4. 2021-07-28
    Survey response — 6 months, dose 2
    MedDRA: Cough, Pre-existing disease, Respiratory tract congestion, Syncope — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Fainting, congestion, cough, mucus, eczema flare
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  5. 2021-07-28
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  6. 2021-08-05
  7. 2021-08-14
    Dose 3 — Pfizer-BioNTech
  8. 2021-08-17
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  9. 2021-11-13
    Survey response — 3 months, dose 3
    MedDRA: Lymphadenopathy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Lymphadenopathy
    MedDRA releases: 2024-11 · check-in free text available
  10. 2021-11-13
    Report sent to call center — 3 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  11. 2021-11-15
  12. 2022-01-11
    Dose 4 — Pfizer-BioNTech
  13. 2022-02-12
    Survey response — 6 months, dose 3
    MedDRA: Pruritus, Syncope, Upper respiratory tract infection, Urticaria — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Lots of fainting still, have had URI, itching and hives
    MedDRA releases: 2024-11 · check-in free text available
  14. 2022-02-12
    Survey response — day 28, dose 4
    MedDRA: Lymphadenopathy, Pruritus, Urticaria — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Itching and hives, swollen lymph nodes
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-02-12
    Report sent to call center — day 28, dose 4
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  16. 2022-02-12
    Report sent to call center — 6 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  17. 2022-02-16
  18. 2022-04-16
    Survey response — 3 months, dose 4
    MedDRA: Asthma, Cough, Infection, Rash, Syncope, Ventricular extrasystoles — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Premature ventricular contractions; infection with cough and asthma attack; rash; daily fainting episodes
    MedDRA releases: 2024-11 · check-in free text available
  19. 2022-07-12
    Survey response — 6 months, dose 4
    MedDRA: Abdominal pain, Haematochezia, Neutrophilia, Productive cough, Secretion discharge, Sinusitis — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Sinus infection; bloody stools; abdominal pain; still have cough with mucus; still having neutrophilia
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-07-26
    Dose 5 — Pfizer-BioNTech
  21. 2022-09-21
    Dose 6 — Pfizer-BioNTech
  22. 2022-09-26
    Health check-in — days 1–6 daily, dose 6
    Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  23. 2022-09-30
    Health check-in — day 7, dose 6
    Feeling: Fair · Headache, Fatigue or tiredness, Diarrhea
    Adult check-in
  24. 2022-10-05
    Survey response — day 14, dose 6
    MedDRA: Abdominal pain, Nausea — Feeling: Fair
    Free text: Gastrointestinal-severe nausea and abdominal pain
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-10-12
    Health check-in — day 21, dose 6
    Feeling: Poor
    Adult check-in
  26. 2022-10-21
    Survey response — day 28, dose 6
    MedDRA: Lymphadenopathy, Streptococcal infection — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Strep with lymph node swelling
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-10-26
    Health check-in — day 35, dose 6
    Feeling: Poor
    Adult check-in
  28. 2022-12-21
    Health check-in — 3 months, dose 6
    Feeling: Fair
    Adult check-in
  29. 2023-03-22
    Survey response — 6 months, dose 6
    MedDRA: Complication associated with device, Foot fracture, Muscle strain, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12020-12-29Moderna
22021-01-26Moderna
32021-08-14Pfizer-BioNTech No
42022-01-11Pfizer-BioNTech No
52022-07-26Pfizer-BioNTech No
62022-09-21Pfizer-BioNTech No

Call center

4 call center cases

1 successful · 3 unsuccessful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 9 — 6 months, dose 2

2021-07-28

Symptoms: Fainting, congestion, cough, mucus, eczema flare

Release 10 — 3 months, dose 3

2021-11-13

Symptoms: Lymphadenopathy

Release 11 — day 28, dose 4

2022-02-12

Symptoms: Itching and hives, swollen lymph nodes

Release 11 — 6 months, dose 3

2022-02-12

Symptoms: Lots of fainting still, have had URI, itching and hives

Release 11 — 3 months, dose 4

2022-04-16

Symptoms: Premature ventricular contractions; infection with cough and asthma attack; rash; daily fainting episodes

Release 12 — 6 months, dose 4

2022-07-12

Symptoms: Sinus infection; bloody stools; abdominal pain; still have cough with mucus; still having neutrophilia

Release 12 — day 14, dose 6

2022-10-05

Symptoms: Gastrointestinal-severe nausea and abdominal pain

Release 12 — day 28, dose 6

2022-10-21

Symptoms: Strep with lymph node swelling

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal pain · · ✓
SDAsthma · · ✓
SDComplication associated with device · · ✓
SDCough ✓ · ✓
SDFoot fracture · · ✓
SDHaematochezia · · ✓
SDInfection · · ✓
SDLymphadenopathy · · ✓
SDMuscle strain · · ✓
SDNausea · · ✓
SDNeutrophilia · · ✓
SDPre-existing disease ✓ · ✓
SDProductive cough · · ✓
SDPruritus · · ✓
SDRash · · ✓
SDRespiratory tract congestion ✓ · ✓
SDSecretion discharge · · ✓
SDSinusitis · · ✓
SDStreptococcal infection · · ✓
SDSyncope ✓ · ✓
SDUpper respiratory tract infection · · ✓
SDUrticaria · · ✓
SDVentricular extrasystoles · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release